1 receptor is relatively resistant to plasminogen activator inhibitor type Single-chain urokinase-type plasminogen activator bound to its
暂无分享,去创建一个
[1] B. Schwartz,et al. Interaction of Single-chain Urokinase and Plasminogen Activator Inhibitor Type 1 (*) , 1995, The Journal of Biological Chemistry.
[2] J. Henkin,et al. Enhancement of the Enzymatic Activity of Single-chain Urokinase Plasminogen Activator by Soluble Urokinase Receptor (*) , 1995, The Journal of Biological Chemistry.
[3] J. Potempa,et al. The serpin superfamily of proteinase inhibitors: structure, function, and regulation. , 1994, The Journal of biological chemistry.
[4] S. Gabbe,et al. Insulinlike growth factors. Their regulation of glucose and amino acid transport in placental trophoblasts isolated from first-trimester chorionic villi. , 1994, The Journal of reproductive medicine.
[5] S. Gabbe,et al. Study of thromboxane and prostacyclin metabolism in an in vitro model of first-trimester human trophoblast. , 1992, American journal of obstetrics and gynecology.
[6] B. Schwartz,et al. Single chain urokinase. Augmentation of enzymatic activity upon binding to monocytes. , 1991, The Journal of biological chemistry.
[7] K. Danø,et al. Plasminogen activation by receptor-bound urokinase. A kinetic study with both cell-associated and isolated receptor. , 1991, The Journal of biological chemistry.
[8] K. Danø,et al. Plasminogen Activation by Receptor-Bound Urokinase , 1991, Seminars in thrombosis and hemostasis.
[9] S. Gillies,et al. High level expression of human proteins in murine hybridoma cells: induction by methotrexate in the absence of gene amplification. , 1991, Biochimica et biophysica acta.
[10] L. Rosenfeld,et al. Interaction of single-chain urokinase-type plasminogen activator with human endothelial cells. , 1990, The Journal of biological chemistry.
[11] D. Loskutoff,et al. Bovine plasminogen activator inhibitor 1: specificity determinations and comparison of the active, latent, and guanidine-activated forms. , 1988, Biochemistry.
[12] E. Kruithof,et al. Plasminogen activator inhibitors--a review. , 1988, Enzyme.
[13] V. Gurewich,et al. Activation of plasminogen by single-chain urokinase or by two-chain urokinase--a demonstration that single-chain urokinase has a low catalytic activity (pro-urokinase). , 1987, Blood.
[14] K. Danø,et al. Plasminogen activator inhibitor from human fibrosarcoma cells binds urokinase-type plasminogen activator, but not its proenzyme. , 1986, The Journal of biological chemistry.
[15] K. Danø,et al. Plasminogen activators catalyse conversion of inhibitor from fibrosarcoma cells to an inactive form with a lower apparent molecular mass , 1986, FEBS letters.
[16] T. Suyama,et al. Proteolytic cleavage of single-chain pro-urokinase induces conformational change which follows activation of the zymogen and reduction of its high affinity for fibrin. , 1985, The Journal of biological chemistry.
[17] D. Loskutoff,et al. Endothelial cells produce a latent inhibitor of plasminogen activators that can be activated by denaturants. , 1985, The Journal of biological chemistry.
[18] E. Kruithof,et al. Demonstration of a fast-acting inhibitor of plasminogen activators in human plasma. , 1984, Blood.